Inventor profile of:

Andreas Hohlbaum

City:

Paunzhausen

Country:

Germany

Published Applications:

32

Last publication date:

2023-01-19

Top Assignees for applications by Andreas Hohlbaum

The entities that hold a legal rights for patent applications filed by inventor Hohlbaum Andreas:

Recent patent applications by Hohlbaum Andreas

Andreas Hohlbaum from Paunzhausen, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-01-19
US20230021168A1
Human necessities

METHODS FOR PREVENTING OR TREATING CERTAIN DISORDERS BY INHIBITING BINDING OF IL-4 AND/OR IL-13 TO THEIR RESPECTIVE RECEPTORS

#2 | 2021-07-01
US20210196788A1
Human necessities

TEAR LIPOCALIN MUTEINS BINDING IL-4 R ALPHA

#3 | 2021-05-20
US20210145934A1
Human necessities

Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors

#4 | 2020-01-09
US20200009223A1
Human necessities

Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors

#5 | 2019-08-08
US20190240289A1
Human necessities

Tear lipocalin muteins binding IL-4 r alpha

#6 | 2019-01-31
US20190030121A1
Human necessities

Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors

#7 | 2019-01-17
US20190015477A1
Human necessities

MUTEINS OF TEAR LIPOCALIN AND METHODS FOR OBTAINING THE SAME

#8 | 2018-11-01
US20180311311A1
Human necessities

METHODS FOR PREVENTING OR TREATING DISORDERS BY INCREASING BIOAVAILABILITY OF IRON AND RELATED PHARMACEUTICAL FORMULATION

#9 | 2017-12-28
US20170369542A1
Chemistry; metallurgy

HUMAN NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (HNGAL) MUTEINS THAT BIND HEPCIDIN AND NUCLEIC ACID ENCODING SUCH

#10 | 2017-11-30
US20170340703A1
Human necessities

Tear lipocalin muteins binding IL-4 R alpha

#11 | 2017-08-10
US20170224770A1
Human necessities

Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation

#12 | 2017-06-22
US20170173112A1
Human necessities

NOVEL BINDING PROTEINS FOR PCSK9

#13 | 2017-04-27
US20170112900A1
Human necessities

Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors

#14 | 2016-09-08
US20160256525A1
Human necessities

Muteins of tear lipocalin and methods for obtaining the same

#15 | 2016-07-14
US20160200780A1
Chemistry; metallurgy

Muteins with tear lipocalin having affinity to human c-met receptor tyrosine kinase and methods for obtaining the same

#16 | 2016-01-28
US20160024161A1
Chemistry; metallurgy

Nucleic acid molecules encoding muteins of human tear lipocalin which bind PCSK9

#17 | 2015-12-24
US20150369821A1
Physics

NOVEL LIPOCALIN-MUTEIN ASSAYS FOR MEASURING HEPCIDIN CONCENTRATION

#18 | 2015-10-15
US20150291675A1
Chemistry; metallurgy

HUMAN NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (HNGAL) MUTEINS THAT BIND HEPCIDIN AND NUCLEIC ACID ENCODING SUCH

#19 | 2015-10-08
US20150283207A1
Human necessities

Tear lipocalin muteins binding IL-4 R alpha

#20 | 2014-12-04
US20140357548A1
Human necessities

Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors

#21 | 2014-10-30
US20140323389A1
Human necessities

Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation

#22 | 2014-09-25
US20140288008A1
Chemistry; metallurgy

Human tear lipocalins which bind PCSK9 and methods of use thereof

#23 | 2014-02-20
US20140051645A1
Chemistry; metallurgy

Muteins of human lipocalin 2 with affinity for CTLA-4

#24 | 2013-11-07
US20130296258A1
Chemistry; metallurgy

Muteins of human lipocalin 2 with affinity for glypican-3 (GPC-3)

#25 | 2013-09-19
US20130244955A1
Chemistry; metallurgy

Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins that bind hepcidin and nucleic acid encoding such

#26 | 2013-04-04
US20130085113A1
Chemistry; metallurgy

Tear lipocalin in muteins binding IL-4 R alpha

#27 | 2013-01-17
US20130017996A1
Human necessities

Muteins of tear lipocalin and methods for obtaining the same

#28 | 2012-08-09
US20120201873A1
Human necessities

CONTROLLED RELEASE FORMULATIONS OF LIPOCALIN MUTEINS

#29 | 2011-04-28
US20110098211A1
Chemistry; metallurgy

Muteins with tear lipocalin having affinity to human c-Met receptor tyrosine kinase and methods for obtaining the same

#30 | 2009-12-10
US20090305982A1
Human necessities

Muteins of tear lipocalin and methods for obtaining the same

#31 | 2009-11-05
US20090274623A1
Human necessities

IN VIVO IMAGING AGENTS FOR MET RECEPTOR TYROSINE KINASE

#32 | 2009-02-12
US20090042785A1
Chemistry; metallurgy

Compound with affinity for the cytotoxic T lymphocyte-associated antigen (CTLA-4)

InventorID:

42247 ⎘